C12N 2760/16162
By genetic engineering
Official title: by genetic engineering
C12N2760/16162 (By genetic engineering) appears on 92 US grants and 123 published applications in this corpus.
Search patents in C12N- Granted patents
- 92
- Published applications
- 123
- Assignees
- 69
- Inventors
- 201
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 3 | 1 |
| 2004 | 0 | 3 |
| 2005 | 2 | 4 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 2 | 3 |
| 2009 | 4 | 9 |
| 2010 | 3 | 4 |
| 2011 | 3 | 5 |
| 2012 | 2 | 8 |
| 2013 | 6 | 2 |
| 2014 | 9 | 10 |
| 2015 | 6 | 4 |
| 2016 | 6 | 10 |
| 2017 | 1 | 4 |
| 2018 | 6 | 8 |
| 2019 | 7 | 7 |
| 2020 | 6 | 9 |
| 2021 | 5 | 3 |
| 2022 | 8 | 9 |
| 2023 | 3 | 5 |
| 2024 | 5 | 6 |
| 2025 | 1 | 5 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hemagglutinin modifications for improved influenza vaccine production10 Mar 2026US 12,569,550 B2St. Jude Children?S Research Hospital
- Influenza b virus mutants and uses therefor19 Aug 2025US 12,390,519 B2FluGen, Inc.
- Recombinant influenza viruses and constructs and uses thereof24 Sep 2024US 12,098,382 B2University of Marylnd, College Park
- Modulation of replicative fitness by deoptimization of synonymous codons17 Sep 2024US 12,090,197 B2The Government of the USA, as represented by the Secretary, Department of Health and Human Services
- Engineered influenza antigenic polypeptides and immunogenic compositions thereof16 Jul 2024US 12,037,364 B2Sanofi Pasteur Limited
- Influenza virus vaccines and uses thereof1 Jan 2026US 2026/0001918 A1Icahn School of Medicine at Mount Sinai
- Deoptimized influenza viruses and methods of treating cancer23 Oct 2025US 2025/0325650 A1Codagenix Inc.
- Rationally designed single-round infectious virus and methods of use thereof9 Oct 2025US 2025/0313813 A1Centre for Virology, Vaccinology and Therapeutics Limited
- Influenza virus mutants and uses therefor20 Mar 2025US 2025/0090649 A1FluGen, Inc.
- Attenuated orthomyxovirus-based vector platform6 Feb 2025US 2025/0043282 A1New York University
Most cited
By later US patents
- Method for producing viruses and vaccines in serum-free culture87US 5,753,489 AImmuno Aktiengesellschaft · 1998
- Recombinant tryptophan mutants of influenza86US 6,322,967 B1Aviron · 2001
- Multi plasmid system for the production of influenza virus40US 8,012,736 B2MedImmune, LLC · 2011
- Methods and interferon deficient substrates for the propagation of viruses37US 6,852,522 B1Mount Sinai School of Medicine of New York University · 2005
- Recombinant tryptophan mutants of influenza36US 6,090,391 AAviron · 2000